您的位置: 首页 > 农业专利 > 详情页

angiotensinogen (agt) RNA compositions and methods of use thereof
专利权人:
ALNYLAM PHARMACEUTICALS; INC.
发明人:
BRIAN BETTENCOURT,DONALD FOSTER,GREGORY HINKLE,KLAUS CHARISSE,MARTIN MAIER,SATYANARAYANA KUCHIMANCHI,STUART MILSTEIN
申请号:
BR112016026950
公开号:
BR112016026950A2
申请日:
2015.05.22
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
The present invention relates to RNA agents, for example, double stranded RNA agents that target the angiotensinogen (agt) gene, and methods of using such RNA agents to inhibit agt expression and methods of treatment. of individuals having an agt-associated disorder, for example, hypertension.a presente invenção refere-se a agentes de rnai, por exemplo, agentes de rnai de filamento duplo, que se direcionam ao gene do angiotensinogênio (agt), e métodos de uso de tais agentes de rnai para inibir expressão de agt e métodos de tratamento de indivíduos tendo um distúrbio associado a agt, por exemplo, hipertensão.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充